Infertility Drugs And Devices Market To Reach US$ 9,702.4 Million By 2027 - Coherent Market Insights

1. INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Infertility Drugs and Devices Market - Overview Endometriosis, ovarian disorders, uterine disorders, tubal disorders, and hormonal disorders are the major cause of female infertility, whereas male infertility is caused by azoospermia, varicocele, ejaculation disorders, and erectile dysfunction. Statistics: The global Infertility Drugs And Devices Market is estimated to account for US$ 9,702.4 Mn in terms of value by the end of 2019. Global Infertility Drugs and Devices Market: Drivers Increasing prevalence of erectile dysfunction is expected to propel growth of the global infertility drugs and devices market over the forecast period. For instance, according to the study ‘The Global Prevalence of Erectile Dysfunction: A Review’, published in BJUI International, in July 2019, the global prevalence of erectile dysfunction was 3–76.5%. Global Infertility Drugs and Devices Market: Opportunities For instance, in May 2018, hormone-binding globulin in human serum and plasma for the diagnosis of infertility, decreased libido and erectile dysfunction in men and polycystic ovarian syndrome in women. DiaSorin S.p.A launched LIAISON test for the measurement of sex Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/infertility-drugs-and-devices-market-4122 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global Infertility Drugs and Devices Market: Restraints Narrowing of insurance coverage for erectile dysfunction treatment is expected to limit growth of the market. A person with a documented medical condition responsible for the cause of erectile dysfunction may incur insurance benefits. However, sex therapies and medications that have not been approved by the FDA have not been covered under insurance. Key Takeaways: The global infertility drugs and devices market was valued at US$ 6,096.7 Mn in 2019 and is forecast to reach a value of US$ 9,702.4 Mn by 2027 at a CAGR of 5.8% between 2020 and 2027. Increasing prevalence of erectile dysfunction is expected to propel growth of the global infertility drugs and devices market over the forecast period. Infertility Drugs segment held dominant position in the global infertility drugs and devices market in 2019, accounting for 77.0% share in terms of value, increasing prevalence of erectile dysfunction is expected to assist the segment growth Market Trends Decreasing birth rate is expected to propel growth of the global infertility drugs and devices market. For instance, according to National Vital Statistics System, the provisional number of births for the U.S. in 2018 was 3,788,235, registering a decrease of 2% from 2017 and the lowest number of births in 32 years. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4122 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION The adoption of Machine Learning and Artificial Intelligence (AI) in diagnosis of infertility is on the rise. For instance, in May 2020, researchers from Peking University, China, proposed a specialized convolutional neural network architecture to accurately classify human sperm heads based on sperm images. Global Infertility Drugs and Devices Market: Competitive Landscape Major players operating in the global infertility drugs and devices market include, Apricus Biosciences, Inc., Bayer AG, Cristalia Produtos Quimicos Farmaceuticos Ltda., Dong-A Pharmaceutical Co. Ltd., Eli Lilly and Company, Meda Pharmaceuticals, Inc., Pfizer, Inc., S.K. Chemicals Co. Ltd., Vivus, Inc. Mylan Pharmaceuticals Inc., Ferring Pharmaceuticals, Cipla Ltd, Aspargo Laboratories, Inc., Aurobindo Pharma Ltd., Lupin Limited, Novartis International AG, Daré Bioscience, Inc., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals, and Dr. Reddys Laboratories Ltd. Global Infertility Drugs and Devices Market: Key Developments May 2020: Ferring Pharmaceuticals announced that MEGASET-HR, a trial comparing Menopur (menotropins for injection indicated for the development of multiple follicles and pregnancy in ovulatory patients participating in an Assisted Reproductive Technology (ART) program) to recombinant follicle stimulating hormone met its primary endpoint, with Menopur-treated patients experiencing a 35.5% OPR per cycle start after fresh transfer. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4122 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved